Session

Liver & biliary (Posters)

IDENTIFICATION OF CT VALUES THAT COULD BE PREDICTIVE OF NECROSIS (N-CTAV) IN HEPATOCELLULAR CARCINOMA AFTER LENVATINIB TREATMENT
IDENTIFICATION OF CT VALUES THAT COULD BE PREDICTIVE OF NECROSIS (N-CTAV) IN HEPATOCELLULAR CARCINOMA AFTER LENVATINIB TREATMENT

Liver & biliary (Posters)  et al.

PROGNOSTIC FACTORS IN PATIENTS RECEIVING PEMBROLIZUMAB WITH ADVANCED BILIARY TRACT CANCER
PROGNOSTIC FACTORS IN PATIENTS RECEIVING PEMBROLIZUMAB WITH ADVANCED BILIARY TRACT CANCER

Liver & biliary (Posters)  et al.

PERFORMANCE OF A 2D-SWE FOR THE DIAGNOSIS OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS REFERENCE METHOD
PERFORMANCE OF A 2D-SWE FOR THE DIAGNOSIS OF LIVER FIBROSIS USING TRANSIENT ELASTOGRAPHY AS REFERENCE METHOD

Liver & biliary (Posters)  et al.

LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE
LIVER FIBROSIS AND STEATOSIS ASSESSMENT USING ELASTOGRAPHIC TECHNIQUES: A COMPARISON BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND ALCOHOLIC LIVER DISEASE

Liver & biliary (Posters)  et al.

INCIDENTAL M2-AMA POSITIVITY BY IMMUNOBLOT IS A STRONG INDICATOR OF PRIMARY BILIARY CHOLANGITIS
INCIDENTAL M2-AMA POSITIVITY BY IMMUNOBLOT IS A STRONG INDICATOR OF PRIMARY BILIARY CHOLANGITIS

Liver & biliary (Posters)  et al.

METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND COVID-19: AN INTERPLAY LEADING TO POOR PATIENT OUTCOME?
METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) AND COVID-19: AN INTERPLAY LEADING TO POOR PATIENT OUTCOME?

Liver & biliary (Posters)  et al.

NOVEL MAFLD CLASSIFICATION: A MORE REALISTIC CONCEPT OF FATTY LIVER DISEASE
NOVEL MAFLD CLASSIFICATION: A MORE REALISTIC CONCEPT OF FATTY LIVER DISEASE

Liver & biliary (Posters)  et al.

LIVER FRAILTY INDEX PREDICTS POOR OUTCOMES IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION OF CIRRHOSIS
LIVER FRAILTY INDEX PREDICTS POOR OUTCOMES IN PATIENTS HOSPITALIZED FOR ACUTE DECOMPENSATION OF CIRRHOSIS

Liver & biliary (Posters)  et al.

THE VALUE OF THIOREDOXIN LEVEL AND ITS GENE POLYMORPHISM IN THE DIAGNOSIS OF POST- HCV HEPATOCELLULAR CARCINOMA
THE VALUE OF THIOREDOXIN LEVEL AND ITS GENE POLYMORPHISM IN THE DIAGNOSIS OF POST- HCV HEPATOCELLULAR CARCINOMA

Liver & biliary (Posters)  et al.

DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN
DISTURBANCES IN SODIUM AND CHLORIDE HOMEOSTASIS PREDICT OUTCOMES IN STABLE AND CRITICALLY ILL PATIENTS WITH CIRRHOSIS – NOT TWO SIDES OF THE SAME COIN

Liver & biliary (Posters)  et al.

ULTRASOUND-BASED ASSESSMENT OF BILIARY MANIFESTATIONS IN ADULT PATIENTS WITH CYSTIC FIBROSIS. PREVALENCE AND RISK FACTORS
ULTRASOUND-BASED ASSESSMENT OF BILIARY MANIFESTATIONS IN ADULT PATIENTS WITH CYSTIC FIBROSIS. PREVALENCE AND RISK FACTORS

Liver & biliary (Posters)  et al.

POINT SHEARWAVE ELASTOGRAPHY TECHNIQUES FOR THE ASSESSMENT OF LIVER STIFFNESS
POINT SHEARWAVE ELASTOGRAPHY TECHNIQUES FOR THE ASSESSMENT OF LIVER STIFFNESS

Liver & biliary (Posters)  et al.

HEPATITIS B VIRUS SCREENING AND PROPHYLAXIS THERAPY IN PATIENTS WITH SOLID TUMORS TREATED WITH ANTICANCER THERAPIES
HEPATITIS B VIRUS SCREENING AND PROPHYLAXIS THERAPY IN PATIENTS WITH SOLID TUMORS TREATED WITH ANTICANCER THERAPIES

Liver & biliary (Posters)  et al.

PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES
PREDICTIVE SCORES IN PATIENTS WITH TYPE 2 DIABETES

Liver & biliary (Posters)  et al.

ANTI-MITOCHONDRIAL ANTIBODY-NEGATIVE PRIMARY BILIARY CHOLANGITIS: EPIDEMIOLOGICAL, CLINICAL, BIOLOGICAL, HISTOLOGICAL AND EVOLUTIONARY CHARACTERISTICS
ANTI-MITOCHONDRIAL ANTIBODY-NEGATIVE PRIMARY BILIARY CHOLANGITIS: EPIDEMIOLOGICAL, CLINICAL, BIOLOGICAL, HISTOLOGICAL AND EVOLUTIONARY CHARACTERISTICS

Liver & biliary (Posters)  et al.

MCP1, CRP AND PROCALCITONIN AS NOVEL DIAGNOSTIC MARKERS IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS
MCP1, CRP AND PROCALCITONIN AS NOVEL DIAGNOSTIC MARKERS IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS

Liver & biliary (Posters)  et al.

THE POSITIVE EFFECTS OF SYNBIOTICS ON LIVER STEATOSIS BY IMPROVING GUT MICROBIOLOGY- RANDOMIZED CONTROLLED TRIAL
THE POSITIVE EFFECTS OF SYNBIOTICS ON LIVER STEATOSIS BY IMPROVING GUT MICROBIOLOGY- RANDOMIZED CONTROLLED TRIAL

Liver & biliary (Posters)  et al.

ESTIMATION OF THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE DURING OBSTRUCTIVE SLEEP APNEA SYNDROME
ESTIMATION OF THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE DURING OBSTRUCTIVE SLEEP APNEA SYNDROME

Liver & biliary (Posters)  et al.

CLINICAL OUTCOMES OF CRYPTOGENIC COMPARED WITH VIRAL CIRRHOSIS
CLINICAL OUTCOMES OF CRYPTOGENIC COMPARED WITH VIRAL CIRRHOSIS

Liver & biliary (Posters)  et al.

RISK FACTORS FOR GALLSTONES IN PATIENTS WITH LIVER CIRRHOSIS
RISK FACTORS FOR GALLSTONES IN PATIENTS WITH LIVER CIRRHOSIS

Liver & biliary (Posters)  et al.

Item 201 - 220 / 226
1 2 3 4 5 6 7 8 9 10
11
12